The Effect of High Protein Enteral Nutrition on Critically Ill Postoperative Children - Trial NCT06411873
Access comprehensive clinical trial information for NCT06411873 through Pure Global AI's free database. This phase not specified trial is sponsored by Indonesia University and is currently Not yet recruiting. The study focuses on Enteral Nutrition,Postoperative,Critically Ill Children. Target enrollment is 76 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Control Group
Interventional
dietary supplement
Sponsor & Location
Indonesia University
Timeline & Enrollment
N/A
May 30, 2024
Dec 30, 2024
Primary Outcome
Nitrogen Balance,I-FABP Levels
Summary
The goal of this clinical trial is o determine the feasibility and efficacy of high enteral
 protein in critically ill postoperative children. It will also learn about the safety of high
 enteral protein for critically ill postoperative children. The main questions it aims to
 answer are:
 
 Does high enteral protein improve nitrogen balance in critically ill postoperative children?
 Does high enteral protein reduce levels of Intestinal Fatty Acid Binding Protein (I-FABP) in
 critically ill postoperative children?
 
 Researchers will compare high enteral protein to a standard enteral protein to see if high
 enteral protein works to improve nitrogen balance and reduces levels of Intestinal Fatty Acid
 Binding Protein (I-FABP) in critically ill postoperative children.
 
 Participants will:
 
 Take high enteral protein or standard enteral protein for 72 hours The nitrogen balance and
 I-FABP levels will be assessed both before and after enteral feeding.
 
 Monitoring and reporting of adverse events and serious adverse events will be conducted in
 accordance with good clinical practice guidelines.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06411873
Non-Device Trial